| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | I-SMAD binding | 2.87e-06 | 17 | 121 | 4 | GO:0070411 | |
| GeneOntologyMolecularFunction | histone modifying activity | 7.84e-05 | 229 | 121 | 8 | GO:0140993 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 7.34e-08 | 8 | 121 | 4 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 2.18e-07 | 10 | 121 | 4 | GO:0071141 | |
| Domain | DWB | 9.70e-08 | 8 | 116 | 4 | SM00524 | |
| Domain | MH2 | 9.70e-08 | 8 | 116 | 4 | PS51076 | |
| Domain | MH1 | 9.70e-08 | 8 | 116 | 4 | PS51075 | |
| Domain | - | 9.70e-08 | 8 | 116 | 4 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 9.70e-08 | 8 | 116 | 4 | IPR013019 | |
| Domain | Dwarfin | 9.70e-08 | 8 | 116 | 4 | IPR013790 | |
| Domain | MH2 | 9.70e-08 | 8 | 116 | 4 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 9.70e-08 | 8 | 116 | 4 | IPR001132 | |
| Domain | MAD_homology1_Dwarfin-type | 6.73e-07 | 12 | 116 | 4 | IPR003619 | |
| Domain | DWA | 6.73e-07 | 12 | 116 | 4 | SM00523 | |
| Domain | MH1 | 6.73e-07 | 12 | 116 | 4 | PF03165 | |
| Domain | SMAD_FHA_domain | 8.13e-07 | 52 | 116 | 6 | IPR008984 | |
| Domain | SMAD_dom-like | 2.43e-06 | 16 | 116 | 4 | IPR017855 | |
| Domain | - | 2.43e-06 | 16 | 116 | 4 | 2.60.200.10 | |
| Domain | zf-C2H2_6 | ZNF569 ZNF317 ZNF354B ZNF16 ZNF526 ZNF117 ZNF497 ZNF606 ZNF107 | 1.51e-04 | 314 | 116 | 9 | PF13912 |
| Pubmed | Smad7 is required for the development and function of the heart. | 2.08e-09 | 6 | 121 | 4 | 18952608 | |
| Pubmed | 9.65e-09 | 8 | 121 | 4 | 10647776 | ||
| Pubmed | 9.65e-09 | 8 | 121 | 4 | 23804438 | ||
| Pubmed | 9.65e-09 | 8 | 121 | 4 | 10708949 | ||
| Pubmed | 1.73e-08 | 9 | 121 | 4 | 19018011 | ||
| Pubmed | 1.73e-08 | 9 | 121 | 4 | 9759503 | ||
| Pubmed | 1.73e-08 | 9 | 121 | 4 | 20007998 | ||
| Pubmed | 1.73e-08 | 9 | 121 | 4 | 10708948 | ||
| Pubmed | 2.88e-08 | 10 | 121 | 4 | 23620745 | ||
| Pubmed | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. | 2.88e-08 | 10 | 121 | 4 | 9436979 | |
| Pubmed | Smad7-induced beta-catenin degradation alters epidermal appendage development. | 4.51e-08 | 11 | 121 | 4 | 16950122 | |
| Pubmed | 6.75e-08 | 12 | 121 | 4 | 14656760 | ||
| Pubmed | Pot1a prevents telomere dysfunction and ATM-dependent neuronal loss. | 1.36e-07 | 14 | 121 | 4 | 24899707 | |
| Pubmed | 1.36e-07 | 14 | 121 | 4 | 16435884 | ||
| Pubmed | 1.85e-07 | 15 | 121 | 4 | 23011393 | ||
| Pubmed | Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. | 2.46e-07 | 16 | 121 | 4 | 19556507 | |
| Pubmed | Smad7 regulates terminal maturation of chondrocytes in the growth plate. | 3.20e-07 | 17 | 121 | 4 | 23994637 | |
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 25141865 | ||
| Pubmed | 4.11e-07 | 18 | 121 | 4 | 19717565 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 4.11e-07 | 18 | 121 | 4 | 35503090 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 9256479 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 21518886 | ||
| Pubmed | SMAD expression in the testis: an insight into BMP regulation of spermatogenesis. | 8.15e-07 | 6 | 121 | 3 | 18069690 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 11850197 | ||
| Pubmed | THSD7A DYNC2H1 GPAM ANKRD6 ELFN2 MYSM1 SETD2 ZNF526 SAMD9L ZNF606 HECTD1 | 1.31e-06 | 493 | 121 | 11 | 15368895 | |
| Pubmed | 1.40e-06 | 24 | 121 | 4 | 16943282 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 15009097 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 10376010 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 1.42e-06 | 7 | 121 | 3 | 11163184 | |
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 15376321 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | COL28A1 ICA1 GPAM HUWE1 GMPS SLC38A10 SAMD9L NEUROD2 PDLIM1 CLTC TMPO CHD6 ATM | 1.85e-06 | 736 | 121 | 13 | 29676528 |
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 2.27e-06 | 8 | 121 | 3 | 19211612 | |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 27375111 | ||
| Pubmed | Single-cell analysis identifies a key role for Hhip in murine coronal suture development. | 2.68e-06 | 28 | 121 | 4 | 34880220 | |
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 3.40e-06 | 9 | 121 | 3 | 24932701 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 21606198 | ||
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 26555259 | ||
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 30134160 | ||
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 15993878 | ||
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 24816837 | ||
| Pubmed | Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. | 3.40e-06 | 9 | 121 | 3 | 14729481 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 18579371 | ||
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 3.40e-06 | 9 | 121 | 3 | 25155999 | |
| Pubmed | Sma- and Mad-related protein 7 (Smad7) is required for embryonic eye development in the mouse. | 3.56e-06 | 30 | 121 | 4 | 23426374 | |
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 4.84e-06 | 10 | 121 | 3 | 29247325 | |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 15221015 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 4.84e-06 | 10 | 121 | 3 | 29986157 | |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 11566864 | ||
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 4.84e-06 | 10 | 121 | 3 | 12543979 | |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 20932476 | ||
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 6.64e-06 | 11 | 121 | 3 | 27741240 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 24008158 | ||
| Pubmed | Sexually dimorphic gene expression in the developing mouse gonad. | 6.71e-06 | 35 | 121 | 4 | 12617826 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 21538804 | ||
| Pubmed | Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. | 8.83e-06 | 12 | 121 | 3 | 15923624 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 17460146 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 27048518 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 30664861 | ||
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 1.15e-05 | 13 | 121 | 3 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 1.15e-05 | 13 | 121 | 3 | 18329379 | |
| Pubmed | Excess NF-κB induces ectopic odontogenesis in embryonic incisor epithelium. | 1.15e-05 | 13 | 121 | 3 | 25376721 | |
| Pubmed | Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. | 1.15e-05 | 13 | 121 | 3 | 18434416 | |
| Pubmed | Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. | 1.15e-05 | 13 | 121 | 3 | 20065295 | |
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 1.15e-05 | 13 | 121 | 3 | 17628518 | |
| Pubmed | Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer. | 1.20e-05 | 2 | 121 | 2 | 21514447 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11557747 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26503245 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 37126020 | ||
| Pubmed | Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility. | 1.20e-05 | 2 | 121 | 2 | 27690720 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36372232 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11165478 | ||
| Pubmed | Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer. | 1.20e-05 | 2 | 121 | 2 | 27692705 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26609934 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34533610 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18616749 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21714724 | ||
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 1.45e-05 | 14 | 121 | 3 | 17670744 | |
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 38951500 | ||
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 26952187 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 1.45e-05 | 14 | 121 | 3 | 33248111 | |
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 16790475 | ||
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 23238123 | ||
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 25274628 | ||
| Pubmed | Constitutively active mutation of ACVR1 in oral epithelium causes submucous cleft palate in mice. | 1.81e-05 | 15 | 121 | 3 | 26116174 | |
| Pubmed | 1.81e-05 | 15 | 121 | 3 | 23946498 | ||
| Pubmed | The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo. | 2.23e-05 | 16 | 121 | 3 | 21907140 | |
| Pubmed | 2.23e-05 | 16 | 121 | 3 | 21939397 | ||
| Pubmed | 2.41e-05 | 48 | 121 | 4 | 27703004 | ||
| Pubmed | SMAD4 is essential for generating subtypes of neurons during cerebellar development. | 2.70e-05 | 17 | 121 | 3 | 22370000 | |
| Pubmed | 2.70e-05 | 17 | 121 | 3 | 27606421 | ||
| Pubmed | 3.23e-05 | 18 | 121 | 3 | 23546880 | ||
| Pubmed | 3.23e-05 | 18 | 121 | 3 | 19914233 | ||
| Pubmed | 3.23e-05 | 18 | 121 | 3 | 27720610 | ||
| Pubmed | BRCA2 is required for neurogenesis and suppression of medulloblastoma. | 3.59e-05 | 3 | 121 | 2 | 17476307 | |
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 3.59e-05 | 3 | 121 | 2 | 30953749 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15084244 | ||
| Pubmed | TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. | 3.59e-05 | 3 | 121 | 2 | 15492226 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21381028 | ||
| Pubmed | Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. | 3.59e-05 | 3 | 121 | 2 | 32875559 | |
| Pubmed | Integrin alpha 11 is a novel type I interferon stimulated gene. | 3.59e-05 | 3 | 121 | 2 | 16697656 | |
| Interaction | CXXC5 interactions | 7.79e-06 | 22 | 119 | 4 | int:CXXC5 | |
| Interaction | SMAD7 interactions | 1.04e-05 | 127 | 119 | 7 | int:SMAD7 | |
| GeneFamily | SMAD family | 4.52e-08 | 8 | 93 | 4 | 750 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZFP3 ZNF569 ZNF180 ZNF317 ZNF354B ZNF16 ZNF526 ZNF117 ZNF497 ZNF606 ZNF107 | 1.13e-03 | 718 | 93 | 11 | 28 |
| GeneFamily | Ankyrin repeat domain containing | 1.56e-03 | 242 | 93 | 6 | 403 | |
| GeneFamily | CD molecules|C-type lectin domain family|Killer cell lectin like receptors | 1.67e-03 | 12 | 93 | 2 | 621 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | THSD7A ZNF569 PARP8 POT1 RANBP6 SAMD9L HNRNPUL2 STARD9 SLCO2A1 | 3.96e-07 | 200 | 121 | 9 | M7532 |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 4.62e-08 | 187 | 121 | 8 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.02e-07 | 190 | 121 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.19e-06 | 198 | 121 | 7 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 1.19e-06 | 198 | 121 | 7 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 121 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.27e-06 | 200 | 121 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 155 | 121 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 155 | 121 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.36e-06 | 156 | 121 | 6 | e6798d2b9c2c1fc6525c24f596f25aa85a375651 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.46e-06 | 167 | 121 | 6 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 168 | 121 | 6 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 168 | 121 | 6 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 168 | 121 | 6 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 1.31e-05 | 189 | 121 | 6 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-05 | 190 | 121 | 6 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.35e-05 | 190 | 121 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-05 | 191 | 121 | 6 | 9b8b64a36e27a2523b8730c7922fd7ad865a021e | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.39e-05 | 191 | 121 | 6 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 193 | 121 | 6 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-05 | 193 | 121 | 6 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | LAM-Endothelial-VasEndo-2|LAM / Condition, Lineage and Cell class | 1.56e-05 | 195 | 121 | 6 | bd11d771938251c091a50d559a2c38d1c4a04033 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-05 | 196 | 121 | 6 | 2849c8f06518c9523093b86167daea4c0b9eda73 | |
| ToppCell | Mild|World / Disease group and Cell class | 1.61e-05 | 196 | 121 | 6 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-05 | 196 | 121 | 6 | bd251231288c900b23d3a676ceec6ac07d228917 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-05 | 197 | 121 | 6 | 550cce374332c49893bcf4ce4b7dceb7f5fe26aa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-05 | 198 | 121 | 6 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-05 | 198 | 121 | 6 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.70e-05 | 198 | 121 | 6 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.70e-05 | 198 | 121 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-05 | 198 | 121 | 6 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.70e-05 | 198 | 121 | 6 | 5607e36f393cb399fcc2504502498453fd32d96b | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 1.75e-05 | 199 | 121 | 6 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | medial-Hematologic-Natural_Killer|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 121 | 6 | 4a75ef6a3b7b5d779a08d039a79322cd60b4ef65 | |
| ToppCell | medial-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 121 | 6 | 52338b8970fba0b32578748ba0bec0b344171ca6 | |
| ToppCell | medial-Hematologic-Natural_Killer-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 121 | 6 | dfcc4976688c7e6df5e41ae77436710075f1f779 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3-NKT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 846d3f0e647040d0e372df0dfcd69a21d5da5aea | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-05 | 200 | 121 | 6 | 98f6a86fbbe5305c71dae91e7278de9813827935 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | c70f06b243ae9804f97308ee02b4b5e1a4a6f9f3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Macrophages|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.80e-05 | 200 | 121 | 6 | d7b89a721988660d8010c804916f5d0ef2520ee2 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage-Macrophages|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-05 | 200 | 121 | 6 | 1ed1c673184f0c6aae04f90edbb1383b1c1f64d9 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_CTL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | b76f000582b38f4c61b44081eba9ae213382cb6f | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.80e-05 | 200 | 121 | 6 | 2a1ba87ca4adf351ef8fa2b3154b86a5407b8f2f | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / Disease condition and Cell class | 1.80e-05 | 200 | 121 | 6 | f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-05 | 133 | 121 | 5 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 148 | 121 | 5 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.16e-05 | 153 | 121 | 5 | d8773ee16c7d3e0834b9f64054d42336d6f9833b | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 154 | 121 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 154 | 121 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.96e-05 | 157 | 121 | 5 | 0362c04b7b0b5017964b3a73ee678ae53e7238d7 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.96e-05 | 157 | 121 | 5 | f3b4cde52423246ae6fc4924cd1ee502cf6c009c | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 158 | 121 | 5 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 158 | 121 | 5 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 158 | 121 | 5 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-05 | 158 | 121 | 5 | 607a13a3991953c1a98cc2fe90099b60487ca4f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-05 | 158 | 121 | 5 | d72d6527dc50207ddbada262460d3c4bac249a19 | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 7.39e-05 | 159 | 121 | 5 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.84e-05 | 161 | 121 | 5 | d0482666479530cd2fd0d229cbb59a1d79839477 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 8.08e-05 | 162 | 121 | 5 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-05 | 164 | 121 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.56e-05 | 164 | 121 | 5 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.81e-05 | 165 | 121 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.81e-05 | 165 | 121 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | Ionocyte-iono-3|World / Class top | 9.06e-05 | 166 | 121 | 5 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-05 | 168 | 121 | 5 | 318fa1bd5a9d6ae95042517ef30515b6416b61e4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-05 | 168 | 121 | 5 | 75b3998aff704a77895ee3723813d8a3819b7cec | |
| ToppCell | ASK454-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.01e-04 | 170 | 121 | 5 | 84705434234bf2fbb5256bd5a1f6ab54c01c5a51 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 171 | 121 | 5 | 943fbca8a6ac04052a2a85aca7b21a3461cd96f7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 171 | 121 | 5 | d1c5540e59c64eb233acab53bfd0d68e922a74bb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 171 | 121 | 5 | e6dfbd2652b67577c8834c05348f62150637f348 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 171 | 121 | 5 | ddaeb96ce9c9c3bf232b4a42266fa2ee7e8f3f41 | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 171 | 121 | 5 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-04 | 172 | 121 | 5 | 68fd03f2c8ee01fe46194400f74ede3830e00f34 | |
| ToppCell | normal-na-Hematopoietic-Progen-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.10e-04 | 173 | 121 | 5 | e666364eb110c1c976e5b09a632dd1454513f131 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 174 | 121 | 5 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 174 | 121 | 5 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 176 | 121 | 5 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 177 | 121 | 5 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | PSB-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.26e-04 | 178 | 121 | 5 | 45bdbb96094c97756e1b6eebd80eadd8472143f2 | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 1.32e-04 | 180 | 121 | 5 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 181 | 121 | 5 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 182 | 121 | 5 | 52baef8173df0a55307c375674a37c2488066738 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 182 | 121 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.43e-04 | 183 | 121 | 5 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 183 | 121 | 5 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-04 | 184 | 121 | 5 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.47e-04 | 184 | 121 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-04 | 185 | 121 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 1.51e-04 | 185 | 121 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 1.54e-04 | 186 | 121 | 5 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 186 | 121 | 5 | d4be02813d590aa7ffe0d1553a27d257b9ab77fe | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 186 | 121 | 5 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.16e-06 | 198 | 121 | 9 | 1082_DN | |
| Disease | bipolar disorder | LETM2 VIPR1 POLR1A THSD7A TDRD9 HUWE1 ANKRD6 TSBP1 STARD9 CMTR2 | 9.65e-05 | 577 | 116 | 10 | MONDO_0004985 |
| Disease | colorectal cancer (is_implicated_in) | 1.19e-04 | 121 | 116 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Breast Cancer, Familial | 2.22e-04 | 30 | 116 | 3 | C0346153 | |
| Disease | coronary artery disease | WIPI1 KCNH7 THSD7A DYNC2H1 PARP8 DUOX2 ANKRD6 SKP2 FARP1 UHRF1 NLRP4 SMAD2 SMAD7 SMAD9 | 2.53e-04 | 1194 | 116 | 14 | EFO_0001645 |
| Disease | infertility (implicated_via_orthology) | 3.18e-04 | 7 | 116 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | endometrial cancer (is_marker_for) | 3.53e-04 | 35 | 116 | 3 | DOID:1380 (is_marker_for) | |
| Disease | endometrial cancer (is_implicated_in) | 3.85e-04 | 36 | 116 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Glioma | 3.93e-04 | 87 | 116 | 4 | C0017638 | |
| Disease | melanoma | 4.56e-04 | 248 | 116 | 6 | C0025202 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | alpha fetoprotein measurement | 6.65e-04 | 100 | 116 | 4 | EFO_0010583 | |
| Disease | Adenoid Cystic Carcinoma | 6.65e-04 | 100 | 116 | 4 | C0010606 | |
| Disease | Small Lymphocytic Lymphoma | 6.75e-04 | 10 | 116 | 2 | C0855095 | |
| Disease | B-CELL MALIGNANCY, LOW-GRADE | 6.75e-04 | 10 | 116 | 2 | C1868683 | |
| Disease | Colorectal Neoplasms | 8.12e-04 | 277 | 116 | 6 | C0009404 | |
| Disease | NG-monomethyl-arginine measurement | 8.23e-04 | 11 | 116 | 2 | EFO_0010510 | |
| Disease | Medulloblastoma | 1.01e-03 | 50 | 116 | 3 | C0025149 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.02e-03 | 112 | 116 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | neutrophil count | USP53 DYNC2H1 PARP8 GPAM SETD2 PDLIM1 PRPF4 OSBPL1A NBPF10 UHRF1 ATP6V0D2 TRAF3IP3 ATP1A4 HYDIN | 1.07e-03 | 1382 | 116 | 14 | EFO_0004833 |
| Disease | Malignant neoplasm of breast | ADAMTS19 ZNF569 DYNC2H1 XRCC2 IFNB1 SETD2 BRCA2 AFP FARP1 ATM IKBKB MRPL9 | 1.08e-03 | 1074 | 116 | 12 | C0006142 |
| Disease | Mammary Carcinoma, Human | 1.13e-03 | 525 | 116 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.13e-03 | 525 | 116 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 1.16e-03 | 527 | 116 | 8 | C1458155 | |
| Disease | atopic asthma | 1.16e-03 | 199 | 116 | 5 | EFO_0010638 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 1.16e-03 | 13 | 116 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 1.32e-03 | 538 | 116 | 8 | C0678222 | |
| Disease | Chronic Lymphocytic Leukemia | 1.34e-03 | 55 | 116 | 3 | C0023434 | |
| Disease | ovarian cancer (is_implicated_in) | 1.41e-03 | 56 | 116 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | biliary atresia | 1.41e-03 | 56 | 116 | 3 | MONDO_0008867 | |
| Disease | celiac disease | 1.57e-03 | 126 | 116 | 4 | EFO_0001060 | |
| Disease | amygdala volume change measurement | 1.77e-03 | 16 | 116 | 2 | EFO_0021490 | |
| Disease | Colorectal Carcinoma | 1.85e-03 | 702 | 116 | 9 | C0009402 | |
| Disease | Bone marrow hypocellularity | 2.25e-03 | 18 | 116 | 2 | C1855710 | |
| Disease | Malignant neoplasm of urinary bladder | 2.37e-03 | 141 | 116 | 4 | C0005684 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.51e-03 | 19 | 116 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.51e-03 | 19 | 116 | 2 | C2936783 | |
| Disease | Adenocarcinoma of prostate | 2.78e-03 | 20 | 116 | 2 | C0007112 | |
| Disease | haptoglobin measurement | 3.06e-03 | 21 | 116 | 2 | EFO_0004640 | |
| Disease | BREAST CANCER | 3.06e-03 | 21 | 116 | 2 | 114480 | |
| Disease | colorectal cancer, colorectal adenoma | 3.10e-03 | 152 | 116 | 4 | EFO_0005406, MONDO_0005575 | |
| Disease | colorectal cancer (is_marker_for) | 3.48e-03 | 157 | 116 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Immunologic Deficiency Syndromes | 3.67e-03 | 23 | 116 | 2 | C0021051 | |
| Disease | insular cortex volume measurement | 3.67e-03 | 23 | 116 | 2 | EFO_0010309 | |
| Disease | small cell lung carcinoma | 3.90e-03 | 80 | 116 | 3 | EFO_0000702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAQILASLQGCRSAK | 601 | Q96P47 | |
| RNTSSICSNEGLIFK | 51 | P22362 | |
| QAIIDCLGSRSNKQR | 221 | P50995 | |
| GFSRRCSKLINSSQL | 1081 | Q12774 | |
| RLTRSNSKCQGQLEV | 36 | P06127 | |
| NQIKCLLVGFSTLRN | 576 | Q8IYT2 | |
| LAAFQTRGNQLCSLI | 276 | Q53GS7 | |
| NRNTALTLACFQGRT | 1251 | O75179 | |
| QNLEQKLSGDSRACR | 511 | Q9Y2G4 | |
| LQVNRLKSAQCGSSI | 211 | P26715 | |
| NLQSVTRGCFDLAQK | 1151 | P49796 | |
| RFLRSKASNCLLQTN | 531 | Q8TE59 | |
| QLERLNLSGNQICSF | 166 | Q6ZRR7 | |
| TGLRKLNISFNEFTC | 716 | Q6ZRR7 | |
| QSQFLQSRNLKCIAL | 776 | Q8N3A8 | |
| QSSCQSGRQLALRLF | 1976 | Q14667 | |
| ALCKLLELQTFGTNN | 296 | Q2VYF4 | |
| QLQKLASERNLFISC | 266 | P42166 | |
| SIQTLKEDCNRLQQG | 436 | O14920 | |
| NQTLLQNCKAFRGAS | 736 | Q9NS40 | |
| CSRLLFLNNISKNEE | 1456 | Q6ZU64 | |
| FPNSELLQRLKNCLS | 796 | Q9BY66 | |
| ISQNLLKRASSRCQS | 371 | P11801 | |
| VLNKGFQSSQALRVC | 356 | Q9NRD8 | |
| QRNNLLCNGLSLKSL | 196 | Q9NVH0 | |
| SSLKENGSQLRCVQQ | 896 | Q9NZ08 | |
| LFGKAECDTRQSLQQ | 1431 | Q9UHC1 | |
| LLKSLLQVSTGFQCN | 431 | Q9Y2G0 | |
| LSCLGLSIVANFQKT | 101 | Q6UX65 | |
| KSRDLLVQQASQCLS | 506 | Q1KMD3 | |
| SGLRFETQLKTLCQF | 111 | P22001 | |
| SCRLQKLGINNVSFS | 666 | Q96MN2 | |
| GNCTKLNLGRVTLSN | 81 | Q9UKX5 | |
| NFLKCSEQLSSGQDI | 761 | Q9Y5G0 | |
| GSRQNLCVNEDVKSL | 261 | Q96FC9 | |
| TDCLNLFTKQEGVRN | 416 | Q9BXW6 | |
| NVFSALCLNARGLQS | 606 | Q7Z6Z7 | |
| QLLQDGLQLRSCTFQ | 976 | O95248 | |
| RNSLTCISDFSLQQL | 206 | Q14392 | |
| TQLKQASLSRVLCDN | 1246 | A1KZ92 | |
| QVGDNRCLLQSLKDS | 1301 | Q8NCM8 | |
| AIQCARQEKSSSGLN | 216 | Q13315 | |
| LSKRQFSSGLNKCVI | 206 | Q9ULG6 | |
| LTGTNKSIRKNRNCS | 1931 | Q9ULT8 | |
| KDSSRILNLCNQSFI | 821 | Q4G0P3 | |
| ISVDNTCSLFRGLQK | 131 | P49915 | |
| NGTRRNISNKDLCAS | 91 | Q9NZS2 | |
| NRSKNQNSKCIGTDL | 236 | P15088 | |
| CINLNSTLFNLGLTK | 641 | Q96M89 | |
| SNLLARKSDVQGSIC | 31 | Q2UY09 | |
| LSDNLCRQTENLKTS | 1616 | P51587 | |
| IKQQRLNRLCEGSSF | 541 | Q96JJ3 | |
| VCDSKRNLSSDQQLI | 1831 | Q8TD26 | |
| KQDLAQGRLTCNDTS | 141 | Q9Y4F1 | |
| IRSCLNNITNRTAKG | 466 | O00409 | |
| LLGFLQRSSNFQCQK | 26 | P01574 | |
| LCTESLKSNGRVQFL | 66 | P58062 | |
| LLGKICNDTRQIFTS | 1836 | Q9UGM3 | |
| LSTLLCEQQQKDGTF | 296 | Q9HBR0 | |
| QESQALAKRSCGLFQ | 406 | P02771 | |
| AQNRIKGCTDNLTLT | 66 | O00151 | |
| TGKALCFSSQQRLAL | 116 | Q05084 | |
| RDLDSKACISIGNQN | 31 | P52564 | |
| TKGITRCLLNETTNN | 1556 | O95602 | |
| LQCGIFQSISFNREK | 26 | Q96CG3 | |
| LSQQDKRRGNQTALC | 441 | Q9UPZ6 | |
| QLQSLFRQCGQVKSI | 791 | Q8NDG6 | |
| EKCFLTQLSGFLANQ | 311 | Q6P3W6 | |
| KSLRSLNNFCSQIGD | 216 | O43172 | |
| DGNKNCRSITVNDLT | 1136 | Q8IVG5 | |
| EAGNFICQALNRKTS | 301 | P35914 | |
| SSTFLPQCNRQKLLE | 806 | Q9HCL2 | |
| DQTNVKLTCLLFSGN | 51 | Q9NUX5 | |
| GLNLTSTFLRKNQCE | 76 | P41222 | |
| ITFSACSRIGSLQKQ | 691 | Q6AI14 | |
| LGNFCRTRSLSPQKQ | 4271 | Q9P2P6 | |
| LKLCGDSRLSNLQRQ | 271 | O60518 | |
| INLTILCSDSNGKNR | 446 | Q96QV1 | |
| RGQLLKLSCNNTLFT | 181 | Q8NGU2 | |
| QRRCKNQNTFLLTTF | 61 | P10153 | |
| FCLGLLSNVNRNSTI | 311 | O15198 | |
| KSRFCLGLLSNVNRN | 306 | Q99717 | |
| RRKQSQCDLLNESTG | 36 | Q8N957 | |
| LRLISAQGCKVDNSS | 211 | Q13733 | |
| INVCNENSLFKSLSR | 931 | Q00610 | |
| TNVNCQRLSSKEDLG | 111 | Q86WS4 | |
| SLQREQLSSCKLRNS | 411 | Q7Z7L8 | |
| LACNFSLSQNRGTVI | 41 | Q9BYD2 | |
| SNLNKERGDCTSLQS | 731 | Q70EK8 | |
| STGNNSRLQAELCQK | 131 | Q92959 | |
| LAKNSNLVRLNLSGC | 226 | Q13309 | |
| LQSTQRSLALAEQKC | 301 | Q9Y228 | |
| ECGRAFNISSNLNKQ | 276 | Q9UII5 | |
| FCLGQLNSDNKSQLV | 296 | O15105 | |
| KLFSSIQGRNVSRSC | 91 | P32241 | |
| AQCGKAFSQRSNLLS | 361 | Q6ZNH5 | |
| RCLFGNQVLQTSSDL | 196 | A4D1E1 | |
| FCLGLLSNVNRNATV | 311 | Q15796 | |
| LSSNGFQNISRCKEK | 716 | Q9BYW2 | |
| NQFSLVSRCLKSNSL | 251 | O43543 | |
| NQCGKTFSLSARLIV | 636 | Q9UJW8 | |
| SCDQKLTNTNRALAL | 496 | Q96T88 | |
| NECGKAFSQRTSLIV | 581 | Q5MCW4 | |
| DCGKTFSQNSVLKNR | 241 | P17020 | |
| EECGKAFNQLSNLTR | 336 | Q03924 | |
| LDCGKRFTQSSNLQQ | 531 | Q8TF50 | |
| TARLNFSGQRNICTL | 306 | Q5MNZ9 | |
| FSGQRNICTLSTIQK | 311 | Q5MNZ9 | |
| QQCLERAQSTAAKLG | 76 | Q9Y2B5 | |
| CQSLLQDRDTLNFFK | 126 | P19224 | |
| NACGKLFSQRSSLTN | 581 | Q96LW1 | |
| FGKRLCNATTQTEEL | 201 | Q9P2Z0 | |
| QILILNQNRFSSCSG | 451 | O60602 | |
| IQILKCGGTARSQNS | 231 | Q5SRN2 | |
| SQCGNAFRTLSALKI | 281 | Q96PQ6 | |
| NGCAKLDRQTQATTL | 226 | Q9P275 | |
| RLSKSQNTVFCGRIQ | 146 | Q96FV9 | |
| QKQVLSQRSSEFCGL | 201 | Q8WXB4 | |
| NECGKTFRVSSQLIQ | 256 | Q96NJ6 | |
| RGCKASLLTQQDYIN | 21 | Q8N8Y2 | |
| NAITVLQAKCRNGSL | 236 | Q5R3F8 | |
| KCRGQQEITNRLSLA | 326 | P20592 | |
| LFSKSSRGCLQNEKQ | 271 | Q5VVJ2 | |
| TNLVAGCLQLNSRNF | 201 | Q15784 | |
| SQSGCLRISIQKLSN | 281 | Q8N987 |